Search clinical trials for: Birch pollen

Total 496 results

Laboratorios Leti, S.L.

Completed

Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)

Allergy to Tree Pollen

Spain
University Hospital, Strasbourg, France

Completed

Resolution of Allergic Inflammation

Grass Pollen Allergic Rhinitis

France
Stallergenes Greer

Completed

Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis

Allergy

Germany
Stallergenes Greer

Completed

Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets

Allergy

France
Stallergenes Greer

Completed

Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

Primary Disease

France, Italy, Spain
Stallergenes Greer

Completed

Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis

Allergy
Stallergenes Greer

Completed

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

Seasonal Allergic Rhinitis

Austria
Stallergenes Greer

Completed

Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis

Allergic Rhinitis Due to Grass Pollens

United States
Mahidol University

Completed

Comparison of Skin Prick Testing Results of Local and Imported Pollen Allergen Extracts and Specific IgE

Immediate Type Hypersensitivity
Stallergenes Greer
Registrat-Mapi

Terminated

International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis (ALTO)

Allergic Rhinitis Due to Grass Pollens

France
Amber Patterson
Nationwide Children's Hospital

Unknown

Safety of Lymph Node Injection for Allergen Immunotherapy

Allergic Rhinitis

United States
ALK-Abelló A/S

Completed

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber (AV-G-03)

Grass Pollen Induced Allergic Rhinoconjunctivitis

Germany
Abbott

Completed

Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinitis

Russian Federation
Biomay AG

Completed

Phase II Study of Grass Pollen Allergy Vaccine BM32

Grass Pollen Allergy

Austria, Belgium, Denmark, Germany, Netherlands, Slovenia
Biomay AG
Medical University of Vienna

Completed

Skin Test Study of BM32

Hypersensitivity

Austria
University of Zurich
AlleCure

Completed

A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy

Rhinoconjunctivitis Due to Grass Pollen Allergy

Switzerland
University Hospital of Cologne

Completed

Tolerability of SLIT With LAIS® 2-Tree Allergoid Tablets

Allergic Rhinitis

Germany
Allergopharma GmbH & Co. KG

Completed

Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children

Allergic Rhinoconjunctivitis

Germany
Gary E. Stein, Pharm.D.

Completed

Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients

Febrile Neutropenia

United States
Association Asthma, Bulgaria
Nasaleze

Unknown

4"S" - Seasonal Symptoms Suppression Study (4"S")

Seasonal Allergic Rhinitis

Bulgaria
Sharp HealthCare

Completed

Prophylactic Ephedrine and Combined Spinal Epidurals for Labor (CEASE)

Labor Pain

United States
ALK-Abelló A/S
Ergomed; ACM Pivotal Global Central Laboratory; Brecon Pharmaceuticals Ltd

Completed

Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense (Osiris)

Rhino-conjunctivitis

Poland
Charite University, Berlin, Germany

Completed

Vitamin D and Grass Pollen Specific Immunotherapy

Allergic Rhinoconjunctivitis

Germany
AstraZeneca

Completed

Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone

Type 2 Diabetes

United States, Mexico, Puerto Rico, Israel, Sweden, Italy, Philippines, Argentina
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

United States
AstraZeneca

Completed

Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg

Type 2 Diabetes

United States, Argentina, Mexico, Israel
Sharp HealthCare

Completed

Changes in Cardiac Output During Delayed Umbilical Cord Clamping

Cardiac Output, Low

United States
Medical University of Silesia

Completed

Grass Pollen Subcutaneous Immunotherapy in Elderly Patients (SCITelderly)

Allergy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults

Allergic Rhinitis

United States
University of California, Davis

Withdrawn

Lactobacillus Acidophilus L92 on Markers of Allergic Inflammation by Nasal Provocation With Grass Pollen

Hayfever
GlaxoSmithKline

Completed

Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber

Rhinitis, Allergic, Seasonal | Seasonal Allergic Rhinitis

Austria
UCB Pharma

Terminated

Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)

Asthma

Italy, Poland, United Kingdom, Germany, Spain, Belgium, South Africa, Czech Republic, Australia, France
Merck Sharp & Dohme LLC

Completed

Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427) (APEGIN)

Hepatitis C | Hepatitis C, Chronic
Aarhus University Hospital
University of Aarhus; ALK-Abelló A/S; Lundbeck Foundation

Completed

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

Allergic Rhinoconjunctivitis
Greer Laboratories

Completed

Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy

Allergy

United States
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)

Hepatitis C | Hepatitis C, Chronic
Pfizer

Completed

Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma

Asthma

United States, Canada
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy (AV-X-02)

Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Spain
Laboratorios Leti, S.L.

Completed

To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction.

Allergy to Pollen

Spain
SK Life Science, Inc.

Completed

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States
University of Aberdeen
NHS Grampian

Completed

Regulatory T-cells in Psoriasis Patients as Targets for Therapy

Psoriasis

United Kingdom
Robert Lodder
University of Kentucky

Completed

Naturlose (D-Tagatose) Efficacy Evaluation Trial (NEET)

Type 2 Diabetes

United States, India
Allergopharma GmbH & Co. KG

Completed

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Allergic Asthma | Rhinoconjunctivitis

Germany
Mannkind Corporation

Completed

Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

Diabetes Type 2

Brazil, Spain, United States, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, United Kingdom
Mannkind Corporation

Completed

Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

Diabetes, Type I

United States, Spain, Brazil, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, United Kingdom
Johann Wolfgang Goethe University Hospital

Completed

Regulatory T-cells After Subcutaneous Immunotherapy (RTCAS)

Grass Pollen Allergy | Specific Immunotherapy

Germany
Henan Provincial People's Hospital

Unknown

Bispectral Index Guiding Etomidate Used in Children Aged 3 to 10 for Clinical Anesthesia Induction

Pediatric | Bispectral Index | Induction | Etomidate
BioTech Tools S.A.

Completed

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM

Hay Fever

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Grass Pollen Allergy

Germany
BioTech Tools S.A.

Completed

Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis

Seasonal Allergic Rhinoconjunctivitis

Belgium

3

Subscribe